What is Mosio?
Mosio specializes in text messaging platforms tailored for clinical research, including trials and behavioral studies. Their technology is designed to boost participant engagement and adherence through automated reminders, appointment notifications, and SMS surveys. The company serves a diverse clientele, encompassing universities, hospitals, pharmaceutical firms, and social researchers, all aiming to refine their communication strategies and data acquisition processes. Having facilitated the transmission of over 150 million messages, Mosio is focused on streamlining research communications and reducing the manual workload for researchers.
How much funding has Mosio raised?
Mosio has raised a total of $96K across 1 funding round:
Debt
$96K
Debt (2021): $96K with participation from PPP
Key Investors in Mosio
PPP
Public-Private Partnership
What's next for Mosio?
Positioned at a significant Series B/C stage, Mosio's recent acquisition of substantial expansion capital indicates a strategic pivot towards scaling operations and market penetration. This financing is expected to fuel product development, enhance sales and marketing efforts, and potentially broaden the company's reach into new research verticals or geographical markets. The company's trajectory suggests a focus on solidifying its market leadership in research communication technology.
See full Mosio company page
